𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differential expression of binding sites for chemokine RANTES on human T lymphocytes

✍ Scribed by Iku Utsunomiya; Kenji Tani; Wanghua Gong; Joost J. Oppenheim; Ji Ming Wang


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
656 KB
Volume
27
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

✦ Synopsis


Differential expression of binding sites for chemokine RANTES on human T lymphocytes

The C-C chemokine RANTES, a T lymphocyte chemoattractant, is considered an important mediator of inflammation, allergy, and host defense against HIV-1 infection. In this study, we investigated the modulation of binding of RANTES to T lymphocytes. Human peripheral blood CD3' T cells, when freshly isolated from buffy-coat blood, expressed a considerable number of high-affinity binding sites for RANTES. These cells also showed significant chemotactic migration in response to RANTES in vitro. After 6-15 h incubation at 37Β°C the binding of RANTES, but not of macrophage inflammatory protein-la (MIP-la) or of monocyte chemotactic protein-3 (MCP-3), consistently increased. Scatchard analyses indicated that the number of binding sites for RANTES increased about threefold by 15 h without any change in the affinity. The increase in RAN-TES binding was no longer detected by 24 h. This increase in the specific binding was mainly attributable to CD4' T cells and was not associated with increased chemotactic activity of these cells in response to RANTES. Incubation with anti-CD3 antibody for 15 h markedly reduced the binding capability of T cells for RANTES and was associated with decreased chemotactic activity. On the other hand, when T cells were incubated with interleukin-2 (IL-2) for 1 week, the specific binding for all three C-C chemokines, RANTES, MIP-la, and MCP-3 was markedly increased in comparison to cells cultured in the absence of IL-2. These results suggest that the expression of binding sites on T cells for RANTES is differentially modulated, indicating the existence of novel receptors for RANTES that do not bind MIP-la.


πŸ“œ SIMILAR VOLUMES


Expression of binding sites for Ξ² chemok
✍ Anuska V. Andjelkovic; Danielle Kerkovich; John Shanley; Lynn Pulliam; Joel S. P πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 604 KB

Astrocytes are major sources of chemokines and are thus critical effectors of central nervous system (CNS) inflammation. However, it is as yet unclear whether these cells, like leukocytes, also possess receptors for chemokines (CCRs). To address this issue, we utilized a novel fluorescence approach

C-X-C and C-C chemokine expression and s
✍ George Kolios; Karen L. Wright; Nicola J. Jordan; Jane B. Leithead; Duncan A. F. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 2 views

Differential chemokine production by colonic epithelial cells is thought to contribute to the characteristic increased infiltration of selected population of leukocytes cells in inflammatory bowel disease. We have previously demonstrated that IL-13 enhances IL-1alpha-induced IL-8 secretion by the co